Personalised medicine

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.  

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

The National Lung Matrix Trial – a £25 million collaboration with pharmaceutical companies and the NHS – has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

New trial results show that a blood test can identify rare types of advanced breast cancer and help patients to access the right treatment more quickly.

We’re investing £56 million into radiotherapy research that will be carried out by a network of specialist institutes across the UK.

The Personalised Breast Cancer Programme in Cambridge is pioneering ways to tackle hard-to-treat breast cancer.

A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.

A new blood test is one of the first to successfully monitor early-stage breast cancer, and could be up to 100 times more sensitive than existing tests.

NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.